Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2026 ,inter alia, to consider and approve the Annual Audited Standalone a Financial Results of the Company for the fourth quarter and financial year ended 31 March 2026 and matters relating to the ensuing Annual General Meeting of the Company, In compliance with Regulation 29 and other applicable provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Detailed disclosure is enclosed.